Patients treated with Dabigatran had lower cerebrovascular-related mortality proportion (23.8% within 7 days and 37.5% in the 8–30 day interval) in comparison to those receiving factor Xa inhibitors, though these findings did not reach statistical significance.
← all excerpts
Mortality after major bleeding in Asian atrial fibrillation patients receiving different direct oral anticoagulants: a nationwide, propensity score study.
1
—
—